Pharmaceutical-Tech Events & Exhibitions section serves as a reference guide to
imminent and existing events occurring in the industry. This directory showcases monthly listings
of contemporaneous tradeshows, exhibitions as well as events.
The premier source for the most relevant updates within the cold chain and temperature management logistics industry is returning for its 15th iteration with the latest information on Health Canada 0069, international GDP requirements, USP initiatives, GS1 Canada updates & more. Join us to cover key concerns involving regulatory, logistics, quality, packaging, security & overall supply chain management, network with your industry peers, and create innovative ideas that will shape the future of the industry.
OTC pharma and consumer healthcare product markets in Asia offer avenue of growth for pharma manufacturers. Coupled with increasing health and wellness awareness, economic growth and increasing consumer self-care by expanding choice and availability of OTC products. Asia’s OTC market is expected to continue growing in the years to come.
IBC’s 7th Annual OTC Pharma Asia is bringing key experts in OTC and VMS to address pertinent issues in Asia – the changing consumer buying behavior and consumer-centric marketing as well as product innovation strategies. The ONLY platform in Asia center staging top leaders in OTC drugs, global pharma manufacturers, retailers, FMCGs, government and regulatory bodies and pharmacies to highlight winning strategies in Asia how OTC and consumer healthcare medicines are accessible, affordable and trusted self-care solutions.
Key Highlights for 2017:
• RX to OTC Technology Trends
• Addressing Pharmacovigilance Aspects for a New OTC Drug
• Rx-to-OTC Switch Prospects
• Manufacturing OTC Drugs
• Industry Dialogue Session
• Exploring New Business Model: Beyond-the-Pill
• Regulatory Updates and Business Strategies
• The Rise of eCommerce
• Consumer-Driven Marketing and Innovation Strategies
All of the Solutions you need to Cost Effectively Develop and Manufacture Quality Product. INTERPHEX is THE pharma, bio and device development/manufacturing event to “Experience Science through Commercialization”.
This 2017, the 2nd Annual Pharmaceutical Congress China, part of IBC’s PharmaCon Series will co-locate 3 events: Pharmaceutical Compliance, Patient-Centered Clinical Trials, and Clinical Trials Site Selection & Quality.
From addressing pharmaceutical compliance challenges and issues, driving clinical operation efficiencies and discovering new clinical design technologies, to clinical trials site selection and quality assurance, Pharmacon China 2017 promises to cover in-depth issues pertaining to compliance and clinical trials in China’s pharmaceutical industry.
Key Highlights for 2017:
• Network with 70+ Distinguished Speakers
• 50+ Sessions to learn and discuss about the hottest topics in China’s pharmaceutical space
• 6 Interactive Workshops to engage in open-learning environment and self-assessment exercises
• Knowledge Sharing via interactive roundtable discussions with key industry experts
• 3 Co-Located Events Under 1 Roof!
• 1 Shared Exhibition Area to showcase YOUR Technologies & Services
SMi is proud to announce the return of their 6th annual Orphan Drugs event to Berlin on the 15th -16th May 2017! The global orphan drug market totaled nearly $123 billion in 2014 and will continue to grow to reach nearly $191 billion by 2019.* With such growth and innovation witnessed in this field now is the best time to discuss and strategize the best route to market. Germany is Europe's largest pharma market but is recognised as having one of the toughest pricing policies in Europe. SMi’s 6th annual Orphan Drugs will discuss the controversial German pricing mechanism as well as bring together leading industry professionals to discuss the latest regulatory developments, explore how to reduce costs and learn from the latest innovations in the orphan drug landscape.
The global market for Highly Potent Active Pharmaceutical Ingredients is currently on a growth fast track, largely driven by its major use in oncology for cancer treatment and more often in the form of ADCs. Over a quarter of drugs worldwide now contain HPAPIs, as they have proven to be more effective than other APIs. However, working with APIs high in potency and cytotoxicity comes with many regulations and requirements, and presents pharmaceutical companies with challenges such as handling, containment, cost and security questions. This conference will cover many important and in-demand aspects of the HPAPI industry, creating a networking platform for industry professionals and key players to share their knowledge and find innovative new solutions
Chemspec Europe 2017 is the international exhibition for fine and speciality chemicals.Known for its focussed profile Chemspec Europe is the key platform for international experts of the fine and speciality chemicals industry. Purchasers and agents looking for highly specialised products and bespoke solutions will find leading companies from all over the world presenting a maximum range of fine and speciality chemicals for many different industries.Excellent networking opportunities and top conferences presenting the latest results of ongoing R&D projects round-off the show.
Chemspec Europe 2017 – The driving force for tomorrow’s business!